Vital Healthcare Property Trust
Vital Healthcare Property Trust Analysis
Overview
Vital Healthcare Property Trust (Vital) is the only specialist, NZX-listed landlord of healthcare real estate in New Zealand and Australia. Vital's portfolio is valued at ~$3.5 billion.
Performance
The following information was extracted from Vital Healthcare Property Trust's Full Year Results, released on 13 August 2026:
Vital Healthcare Property Trust (Vital) is pleased to report its financial results for the 12 months ended 30 June 2026.
FY26 was a transformational year for Vital, marked by the transition to an internalised management model on 1 January 2026. Internalisation has strengthened governance, increased alignment with Unit Holders and established a scalable operating platform that positions Vital to capture the full benefits of future growth and value creation.
FY26 highlights include:
Financial:
- AFFO increased to $86.9 million (+23.5%) or 11.50 cents per unit (+10.5%)
- Net property income up 9.0% to $162.2 million, with like-for-like income growth of 4.1%, on a constant currency basis
- Distributions maintained at 9.75 cents per unit on an AFFO payout ratio of 84.8%
- Management Expense Ratio of 0.53% following Internalisation
Portfolio:
- 27,600 square metres of leasing activity completed delivering portfolio occupancy of 97.2%
- Unrealised portfolio valuation gain of $60.1 million
- Key hospital operator partners trading at Vital’s benchmark 50% rent/EBITDAR
- GRESB Global Sector Leader for ESG in Listed Healthcare for Standing Investments and Development
Development:
- Completed three developments at a total cost of $229.1 million
- Coomera Health Campus – Stage 1 (QLD) (A$47.5 million) and Macarthur Health Precinct – Stage 2 (NSW) (A$103.0 million) developments activated
- RDX (QLD) and Endoscopy Auckland (Auckland) awarded Green Star certification
Capital Management:
- $1.4 billion of debt refinanced on improved terms and no debt maturities before April 2028
- Completed $97.9 million of asset recycling divestments
- Gearing down to 39.6% (from 42.1%)
Disclaimer: This section is provided as general information only. It is not intended as a substitute for legal or professional advice to company directors and officers or investors. NZX Limited disclaims any liability arising from the use of this information.
About Company
Board & Leadership
| Graham Stuart | Independent Chairman |
|---|---|
| Chris Adams | Chief Executive Officer |
| Michael Groth | Chief Financial Officer |
| Angela Bull | Independent Director |
| Mark Menhinnitt | Independent Director |
| Michael Stanford | Independent Director |
| Mike Brady | Director |
| Zachary Vaughan | Director |
| Vanessa Flax | Company Secretary |
Company Summary
| First Listed | 7th Sep 1999 |
|---|---|
| Primary Listing Venue | NZ |
| Solicitor | Bell Gully |
| Auditor | Deloitte, Auckland |
| Share Registry | Computershare Investor Services Limited |
| End of Financial Year | June |